Beckman Coulter Pays Roche $27.5M to License RT-PCR Technology for IVD Use | GenomeWeb
NEW YORK (GenomeWeb News) - Beckman Coulter today said it has acquired an in vitro diagnostics product license to all of Roche's real-time PCR patents and pending patent applications.
 
In exchange Beckman Coulter will pay Roche a one-time license fee of $27.5 million and will also pay royalties on sales of all licensed products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.